Molecular strategies for targeting antioxidants to mitochondria: Therapeutic implications

Antioxidants and Redox Signaling

Volumn 22, Issue 8, 2015, Pages 686-729

  Apostolova, Nadezda ^a,b   Victor, Victor M ^b,c,d  

^a UNIVERSITAT JAUME I   (Spain)

^b UNIVERSITY OF VALENCIA   (Spain)

^c HOSPITAL UNIVERSITARIO DR PESET   (Spain)

^d Department of Physiology Faculty of Medicine University of Valencia ^*  (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ALKALOID; AMINO ACID DERIVATIVE; ANTIOXIDANT; BERBERINE; CATION; CELL PENETRATING PEPTIDE; DECYLRHODAMINE 19; DECYLTRIPHENYLPHOSPHONIUM; DEQUALINIUM; LIPOSOME; MACROGOL; MANGANESE PORPHYRIN; MITOQUINONE; NANOCARRIER; PALMATINE; PLASTOQUINONE; POLYGLACTIN; PORPHYRIN; REACTIVE NITROGEN SPECIES; REACTIVE OXYGEN METABOLITE; RHODAMINE; SS 31; TETRAPEPTIDE; UNCLASSIFIED DRUG; XJB PEPTIDE;

APOPTOSIS; AUTOPHAGY; BIODEGRADABILITY; CANCER THERAPY; CELL ORGANELLE; CELLULAR DISTRIBUTION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INSULIN SENSITIVITY; LIPID PEROXIDATION; LIPOPHILICITY; META ANALYSIS (TOPIC); MICROENVIRONMENT; MITOCHONDRIAL DYNAMICS; MITOCHONDRIAL MEMBRANE POTENTIAL; MITOCHONDRIAL RESPIRATION; MITOCHONDRION; NANOTECHNOLOGY; NITROSATIVE STRESS; NONHUMAN; OXIDATION REDUCTION REACTION; OXIDATIVE PHOSPHORYLATION UNCOUPLING; OXIDATIVE STRESS; PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROTEIN TARGETING; REVIEW; ANIMAL; METABOLISM;

ANIMALS; ANTIOXIDANTS; APOPTOSIS; AUTOPHAGY; HUMANS; MITOCHONDRIA; OXIDATION-REDUCTION;

EID: 84923914528     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2014.5952     Document Type: Review

References (380)

1. Adair JC, Knoefel JE, and Morgan N. Controlled trial of N-Acetylcysteine for patients with probable Alzheimers disease. Neurology 57: 1515-1517, 2001
2. Adlam VJ, Harrison JC, Porteous CM, James AM, Smith RA, Murphy MP, and Sammut IA. Targeting an antioxidant to mitochondria decreases cardiac ischemia-reperfusion injury. FASEB J 19: 1088-1095, 2005
3. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, and Walter P. Molecular Biology of the Cell, 4th Edition. New York: Garland Science, 2002
4. Alipour M, Omri A, Smith MG, and Suntres ZE. Prophylactic effect of liposomal N-Acetylcysteine against LPS-induced liver injuries. J Endotoxin Res 13: 297-304, 2007
5. Alirol E, James D, Huber D, Marchetto A, Vergani L, Martinou JC, and Scorrano L. The mitochondrial fission protein hFis1 requires the endoplasmic reticulum gateway to induce apoptosis. Mol Biol Cell 17: 4593-4605, 2006
6. Anders MW. Putting bioactivation reactions to work: targeting antioxidants to mitochondria. Chem Biol Interact 192: 8-13, 2011
7. Anderson EJ, Lustig ME, Boyle KE, Woodlief TL, Kane DA, Lin CT, Price JW 3rd, Kang L, Rabinovitch PS, Szeto HH, Houmard JA, Cortright RN, Wasserman DH, and Neufer PD. Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans. J Clin Invest 119: 573-581, 2009
8. Anderson EJ, Thayne K, Harris M, Carraway K, and Shaikh SR. Aldehyde stress and upregulation of Nrf2 mediated antioxidant systems accompany functional adaptations in cardiac mitochondria from mice fed n3 polyunsaturated fatty acids. Biochem J 441: 359-366, 2012
9. Andersson DC, Fauconnier J, Yamada T, Lacampagne A, Zhang SJ, Katz A, and Westerblad H. Mitochondrial production of reactive oxygen species contributes to the badrenergic stimulation of mouse cardiomycytes. J Physiol 589: 1791-1801, 2011
10. Andrews ZB, Horvath B, Barnstable CJ, Elsworth J, Yang L, Beal MF, Roth RH, Matthews RT, and Horvath TL. Uncoupling protein-2 is critical for nigral dopamine cell survival in a mouse model of Parkinsons disease. J Neurosci 25: 184-191, 2005
11. Antonenko YN, Avetisyan AV, Bakeeva LE, Chernyak BV, Chertkov VA, Domnina LV, Ivanova OY, Izyumov DS, Khailova LS, Klishin SS, Korshunova GA, Lyamzaev KG, Muntyan MS, Nepryakhina OK, Pashkovskaya AA, Pletjushkina OY, Pustovidko AV, Roginsky VA, Rokitskaya TI, Ruuge EK, Saprunova VB, Severina II, Simonyan RA, Skulachev IV, Skulachev MV, Sumbatyan NV, Sviryaeva IV, Tashlitsky VN, Vassiliev JM, Vyssokikh MY, Yaguzhinsky LS, Zamyatnin AA, Jr., and Skulachev VP. Mitochondria-Targeted plastoquinone derivatives as tools to interrupt execution of the aging program 1. Cationic plastoquinone derivatives: synthesis and in vitro studies. Biochemistry (Mosc) 73: 1273-1287, 2008
12. Antoniades C, Bakogiannis C, Tousoulis D, Reilly S, Zhang MH, Paschalis A, Antonopoulos AS, Demosthenous M, Miliou A, Psarros C, Marinou K, Sfyras N, Economopoulos G, Casadei B, Channon KM, and Stefanadis C. Preoperative atorvastatin treatment in CABG patients rapidly improves vein graft redox state by inhibition of Rac1 and NADPH-oxidase activity. Circulation 122: 66-73, 2010
13. Asin-Cayuela J, Manas AR, James AM, Smith RA, and Murphy MP. Fine-Tuning the hydrophobicity of a mitochondria-Targeted antioxidant. FEBS Lett 571: 9-16, 2004
14. Aviram M, Rosenblat M, Bisgaier CL, Newton RS, Primo-Parmo SL, and La Du BN. Paraoxonase inhibits highdensity lipoprotein oxidation and preserves its functions A possible peroxidative role for paraoxonase. J Clin Invest 101: 1581-1590, 1998
15. Azad MB, Chen Y, and Gibson SB. Regulation of autophagy by reactive oxygen species (ROS): implications for cancer progression and treatment. Antioxid Redox Signal 11: 777-790, 2009
16. Bach D, Pich S, Soriano FX, Vega N, Baumgartner B, Oriola J, Daugaard JR, Lloberas J, Camps M, Zierath JR, Rabasa-Lhoret R, Wallberg-Henriksson H, Laville M, Palacín M, Vidal H, Rivera F, Brand M, and Zorzano A. Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism A novel regulatory mechanism altered in obesity. J Biol Chem 278: 17190-17197, 2003
17. Baker K, Bucay-Marcus C, Huffman C, Kruk H, Malfroy B, and Doctrow SR. Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury. J Pharmacol Exp Ther 284: 215-221, 1998
18. Belardinelli R, Mucaj A, Lacalaprice F, Solenghi M, Tiano L, and Littarru GP. Coenzyme Q10 improves contractility of dysfunctional myocardium in chronic heart failure. Biofactors 25: 137-145, 2005
19. Berk L, Jorm AF, Kelly CM, Dodd S, and Berk M. Development of guidelines for caregivers of people with bipolar disorder: a Delphi expert consensus study. Bipolar Disord 13: 556-570, 2011
20. Bhatt JK, Thomas S, and Nanjan MJ. Resveratrol supplementation improves glycemic control in type 2 diabetes mellitus. Nutr Res 32: 537-541, 2012
21. Biasutto L, Mattarei A, Marotta E, Bradaschia A, Sassi N, Garbisa S, Zoratti M, and Paradisi C. Development of mitochondria-Targeted derivatives of resveratrol. Bioorg Med Chem Lett 18: 5594-5597, 2008
22. Bincoletto C, Bechara A, Pereira GJ, Santos CP, Antunes F, Peixoto da-Silva J, Muler M, Gigli RD, Monteforte PT, Hirata H, Jurkiewicz A, and Smaili SS. Interplay between apoptosis and autophagy, a challenging puzzle: new perspectives on antitumor chemotherapies. Chem Biol Interact 206: 279-288, 2013
23. Birk AV, Chao WM, Bracken C, Warren JD, and Szeto HH. Targeting mitochondrial cardiolipin and the cytochrome c/cardiolipin complex to promote electron transport and optimize mitochondrial ATP synthesis. Br J Pharmacol 171: 2017-2028, 2014
24. Biswas S, Dodwadkar NS, Deshpande PP, and Torchilin VP. Liposomes loaded with paclitaxel and modified with novel triphenylphosphonium-PEG-PE conjugate possess low toxicity, target mitochondria and demonstrate enhanced antitumor effects in vitro and in vivo. J Control Release 159: 393-402, 2012
25. Blaikie FH, Brown SE, Samuelsson LM, Brand MD, Smith RA, and Murphy MP. Targeting dinitrophenol to mitochondria: limitations to the development of a selflimiting mitochondrial protonophore. Biosci Rep 26: 231-243, 2006
26. Boddapati SV, DSouza GG, Erdogan S, Torchilin VP, and Weissig V. Organelle-Targeted nanocarriers: specific delivery of liposomal ceramide to mitochondria enhances its cytotoxicity in vitro and in vivo. Nano Lett 8: 2559-2563, 2008
27. Bolisetty S, Traylor AM, Kim J, Joseph R, Ricart K, Landar A, and Agarwal A. Heme oxygenase-1 inhibits renal tubular macroautophagy in acute kidney injury. J Am Soc Nephrol 21: 1702-1712, 2010
28. Bourens M, Fontanesi F, Soto IC, Liu J, and Barrientos A. Redox and reactive oxygen species regulation of mitochondrial cytochrome c oxidase biogenesis. Antioxid Redox Signal 19: 1940-1952, 2013
29. Brasnyo P, Molnar GA, Mohas M, Marko L, Laczy B, Cseh J, Mikolás E, Szijártó IA, Mérei A, Halmai R, Mészáros LG, Sümegi B, and Wittmann I. Resveratrol improves insulin sensitivity, reduces oxidative stress and activates the Akt pathway in type 2 diabetic patients. Br J Nutr 106: 383-389, 2011
30. Brookes PS, Levonen AL, Shiva S, Sarti P, and Darley-Usmar VM. Mitochondria: regulators of signal transduction by reactive oxygen and nitrogen species. Free Radic Biol Med 33: 755-764, 2002
31. Brown SE, Ross MF, Sanjuan-Pla A, Manas AR, Smith RA, and Murphy MP. Targeting lipoic acid to mitochondria: synthesis and characterization of a triphenylphosphoniumconjugated alpha-lipoyl derivative. Free Radic Biol Med 42: 1766-1780, 2007
32. Buckler KJ. Effects of exogenous hydrogen sulphide on calcium signalling, background (TASK) K channel activity and mitochondrial function in chemoreceptor cells. Pflugers Arch 463: 743-754, 2012
33. Burton GW and Ingold KU. Beta-carotene: an unusual type of lipid antioxidant. Science 224: 569-573, 1984
34. Campello S, Lacalle RA, Bettella M, Manes S, Scorrano L, and Viola A. Orchestration of lymphocyte chemotaxis by mitochondrial dynamics. J Exp Med 203: 2879-2886, 2006
35. Campello S and Scorrano L. Mitochondrial shape changes: orchestrating cell pathophysiology. EMBO Rep 11: 678-684, 2010
36. Cereghetti GM, Costa V, and Scorrano L. Inhibition of Drp1-dependent mitochondrial fragmentation and apoptosis by a polypeptide antagonist of calcineurin. Cell Death Differ 17: 1785-1794, 2010
37. Cereghetti GM, Stangherlin A, de Martins BO, Chang CR, Blackstone C, Bernardi P, and Scorrano L. Dephosphorylation by calcineurin regulates translocation of Drp1 to mitochondria. Proc Natl Acad Sci U S A 105: 15803-15808, 2008
38. Chacko BK, Reily C, Srivastava A, Johnson MS, Ye Y, Ulasova E, Agarwal A, Zinn KR, Murphy MP, Kalyanaraman B, and Darley-Usmar V. Prevention of diabetic nephropathy in Ins2( +/)(AkitaJ) mice by the mitochondria-Targeted therapy MitoQ. Biochem J 432: 9-19, 2010
39. Chacko BK, Srivastava A, Johnson MS, Benavides GA, Chang MJ, Ye Y, Jhala N, Murphy MP, Kalyanaraman B, and Darley-Usmar VM. Mitochondria-Targeted ubiquinone (MitoQ) decreases ethanol-dependent micro and macro hepatosteatosis. Hepatology 54: 153-163, 2011
40. Chandran K, Aggarwal D, Migrino RQ, Joseph J, McAllister D, Konorev EA, Antholine WE, Zielonka J, Srinivasan S, Avadhani NG, and Kalyanaraman B. Doxorubicin inactivates myocardial cytochrome c oxidase in rats: cardioprotection by Mito-Q. Biophys J 96: 1388-1398, 2009
41. Chen K, Craige SE, and Keaney JF, Jr. Downstream targets and intracellular compartmentalization in Nox signaling. Antioxid Redox Signal 11: 2467-2480, 2009
42. Chen KH, Guo X, Ma D, Guo Y, Li Q, Yang D, Li P, Qiu X, Wen S, Xiao RP, and Tang J. Dysregulation of HSG triggers vascular proliferative disorders. Nat Cell Biol 6: 872-883, 2004
43. Chen Y, Azad MB, and Gibson SB. Superoxide is the major reactive oxygen species regulating autophagy. Cell Death Differ 16: 1040-1052, 2009
44. Chen Y, McMillan-Ward E, Kong J, Israels SJ, and Gibson SB. Mitochondrial electron-Transport-chain inhibitors of complexes I and II induce autophagic cell death mediated by reactive oxygen species. J Cell Sci 120: 4155-4166, 2007
45. Chernyak BV, Antonenko YN, Galimov ER, Domnina LV, Dugina VB, Zvyagilskaya RA, Ivanova OY, Izyumov DS, Lyamzaev KG, Pustovidko AV, Rokitskaya TI, Rogov AG, Severina II, Simonyan RA, Skulachev MV, Tashlitsky VN, Titova EV, Trendeleva TA, and Shagieva GS. Novel mitochondria-Targeted compounds composed of natural constituents: conjugates of plant alkaloids berberine and palmatine with plastoquinone. Biochemistry (Mosc) 77: 983-995, 2012
46. Cho J, Won K, Wu D, Soong Y, Liu S, Szeto HH, and Hong MK. Potent mitochondria-Targeted peptides reduce myocardial infarction in rats. Coron Artery Dis 18: 215-220, 2007
47. Cho S, Szeto HH, Kim E, Kim H, Tolhurst AT, and Pinto JT A novel cell-permeable antioxidant peptide, SS31, attenuates ischemic brain injury by down-regulating CD36. J Biol Chem 282: 4634-4642, 2007
48. Chouchani ET, Methner C, Nadtochiy SM, Logan A, Pell VR, Ding S, James AM, Cochemé HM, Reinhold J, Lilley KS, Partridge L, Fearnley IM, Robinson AJ, Hartley RC, Smith RA, Krieg T, Brookes PS, and Murphy MP. Cardioprotection by S-nitrosation of a cysteine switch on mitochondrial complex I. Nat Med 19: 753-759, 2013
49. Cipolat S, Martins de Brito O, Dal Zilio B, and Scorrano L. OPA1 requires mitofusin 1 to promote mitochondrial fusion. Proc Natl Acad Sci U S A 101: 15927-15932, 2004
50. Cochemé HM, Kelso GF, James AM, Ross MF, Trnka J, Mahendiran T, Asin-Cayuela J, Blaikie FH, Manas AR, Porteous CM, Adlam VJ, Smith RA, and Murphy MP. Mitochondrial targeting of quinones: therapeutic implications. Mitochondrion 7: 94-102, 2007
51. Coetzee WA. Multiplicity of effectors of the cardioprotective agent, diazoxide. Pharmacol Ther 140: 167-175, 2013
52. Colognato R, Laurenza I, Fontana I, Coppedé F, Siciliano G, Coecke S, Aruoma OI, Benzi L, and Migliore L. Modulation of hydrogen peroxide-induced DNA damage, MAPKs activation and cell death in PC12 by ergothioneine. Clin Nutr 25: 135-145, 2006
53. Conti B, Sugama S, Lucero J, Winsky-Sommerer R, Wirz SA, Maher P, Andrews Z, Barr AM, Morale MC, Paneda C, Pemberton J, Gaidarova S, Behrens MM, Beal F, Sanna PP, Horvath T, and Bartfai T. Uncoupling protein 2 protects dopaminergic neurons from acute 1, 2, 3, 6-methyl-phenyl-Tetrahydropyridine toxicity. J Neurochem 93: 493-501, 2005
54. Cook NR, Albert CM, Gaziano JM, Zaharris E, MacFadyen J, Danielson E, Buring JE, and Manson JE A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Womens Antioxidant Cardiovascular Study. Arch Intern Med 167: 1610-1618, 2007
55. Cooper CE and Giulivi C. Nitric oxide regulation of mitochondrial oxygen consumption II. molecular mechanism and tissue physiology. Am J Physiol Cell Physiol 292: 1993-2003, 2007
56. Correia SC, Santos RX, Cardoso SM, Santos MS, Oliveira CR, and Moreira PI. Cyanide preconditioning protects brain endothelial and NT2 neuron-like cells against glucotoxicity: role of mitochondrial reactive oxygen species and HIF-1a. Neurobiol Dis 45: 206-218, 2012
57. Cortes CJ and La Spada AR. The many faces of autophagy dysfunction in Huntingtons disease: from mechanism to therapy. Drug Discov Today 19: 963-971, 2014
58. Costa V, Giacomello M, Hudec R, Lopreiato R, Ermak G, Lim D, Malorni W, Davies KJ, Carafoli E, and Scorrano L. Mitochondrial fission and cristae disruption increase the response of cell models of Huntingtons disease to apoptotic stimuli. EMBO Mol Med 2: 490-503, 2010
59. Crandall JP, Oram V, Trandafirescu G, Reid M, Kishore P, Hawkins M, Cohen HW, and Barzilai N. Pilot study of resveratrol in older adults with impaired glucose tolerance. J Gerontol A Biol Sci Med Sci 67: 1307-1312, 2012
60. Cristol JP, Bosc JY, Badiou S, Leblanc M, Lorrho R, Descomps B, and Canaud B. Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation. Nephrol Dial Transplant 12: 2312-2317, 1997
61. Cuzzocrea S, Mazzon E, Costantino G, Serraino I, Dugo L, Calabrò G, Cucinotta G, De Sarro A, and Caputi AP. Beneficial effects of n-Acetylcysteine on ischaemic brain injury. Br J Pharmacol 130: 1219-1226, 2000
62. Dague E, Genet G, Lachaize V, Guilbeau-Frugier C, Fauconnier J, Mias C, Payré B, Chopinet L, Alsteens D, Kasas S, Severac C, Thireau J, Heymes C, Honton B, Lacampagne A, Pathak A, Sénard JM, and Galés C. Atomic force and electron microscopic-based study of sarcolemmal surface of living cardiomyocytes unveils unexpected mitochondrial shift in heart failure. J Mol Cell Cardiol 74: 162-172, 2014
63. Dahm CC, Moore K, and Murphy MP. Persistent S-nitrosation of complex I and other mitochondrial membrane proteins by S-nitrosothiols but not nitric oxide or peroxynitrite: implications for the interaction of nitric oxide with mitochondria. J Biol Chem 281: 10056-10065, 2006
64. Dai DF, Hsieh EJ, Chen T, Menendez LG, Basisty NB, Tsai L, Beyer RP, Crispin DA, Shulman NJ, Szeto HH, Tian R, MacCoss MJ, and Rabinovitch PS. Global proteomics and pathway analysis of pressure-overloadinduced heart failure and its attenuation by mitochondrialtargeted peptides. Circ Heart Fail 6: 1067-1076, 2013
65. Daiber A. Redox signaling (cross-Talk) from and to mitochondria involves mitochondrial pores and reactive oxygen species. Biochim Biophys Acta 1797: 897-906, 2010
66. Danielson SR and Andersen JK. Oxidative and nitrative protein modifications in Parkinsons disease. Free Radic Biol Med 44: 1787-1794, 2008
67. de Brito OM and Scorrano L. Mitofusin 2 tethers endoplasmic reticulum to mitochondria. Nature 456: 605-610, 2008
68. de Oliveira BF, Veloso CA, Nogueira-Machado JA, and Martins Chaves M. High doses of in vitro beta-carotene, alpha-Tocopherol and ascorbic acid induce oxidative stress and secretion of IL-6 in peripheral blood mononuclear cells from healthy donors. Curr Aging Sci 5: 148-156, 2012
69. Desai SP, Bhatia SN, Toner M, and Irimia D. Mitochondrial localization and the persistent migration of epithelial cancer cells. Biophys J 104: 2077-2088, 2013
70. Dickey JS, Gonzalez Y, Aryal B, Mog S, Nakamura AJ, Redon CE, Baxa U, Rosen E, Cheng G, Zielonka J, Parekh P, Mason KP, Joseph J, Kalyanaraman B, Bonner W, Herman E, Shacter E, and Rao VA. Mito-Tempol and dexrazoxane exhibit cardioprotective and chemotherapeutic effects through specific protein oxidation and autophagy in a syngeneic breast tumor preclinical model. PLoS One 8: e70575, 2013
71. DSouza GG, Boddapati SV, and Weissig V. Mitochondrial leader sequence-plasmid DNA conjugates delivered into mammalian cells by DQAsomes co-localize with mitochondria. Mitochondrion 5: 352-358, 2005
72. DSouza GG, Cheng SM, Boddapati SV, Horobin RW, and Weissig V. Nanocarrier-Assisted sub-cellular targeting to the site of mitochondria improves the pro-Apoptotic activity of paclitaxel. J Drug Target 16: 578-585, 2008
73. Di Sario A, Bendia E, Taffetani S, Omenetti A, Candelaresi C, Marzioni M, De Minicis S, and Benedetti A. Hepatoprotective and antifibrotic effect of a new silybinphosphatidylcholine-vitamin E complex in rats. Dig Liver Dis 37: 869-876, 2005
74. Dimmer KS, Fritz S, Fuchs F, Messerschmitt M, Weinbach N, Neupert W, and Westermann B. Genetic basis of mitochondrial function and morphology in Saccharomyces cerevisiae. Mol Biol Cell 13: 847-853, 2002
75. Doctrow SR, Liesa M, Melov S, Shirihai OS, and Tofilon P. Salen Mn complexes are superoxide dismutase/catalase mimetics that protect the mitochondria. Curr Inorg Chem 2: 325-334, 2012
76. Dong KK, Damaghi N, Kibitel J, Canning MT, Smiles KA, and Yarosh DB A comparison of the relative antioxidant potency of L-ergothioneine and idebenone. J Cosmet Dermatol 6: 183-188, 2007
77. Doughan AK and Dikalov SI. Mitochondrial redox cycling of mitoquinone leads to superoxide production and cellular apoptosis. Antioxid Redox Signal 9: 1825-1836, 2007
78. Dröge W. Free radicals in the physiological control of cell function. Physiol Rev 82: 47-49, 2002
79. Dröse S, Brandt U, and Wittig I. Mitochondrial respiratory chain complexes as sources and targets of thiol-based redox-regulation. Biochim Biophys Acta 1844: 1344-1354, 2014
80. Dröse S, Hanley PJ, and Brandt U. Ambivalent effects of diazoxide on mitochondrial ROS production at respiratory chain complexes I and III. Biochim Biophys Acta 1790: 558-565, 2009
81. Du L, Miao X, Gao Y, Jia H, Liu K, and Liu Y. The protective effects of Trolox-loaded chitosan nanoparticles against hypoxia-mediated cell apoptosis. Nanomedicine 10: 1411-1420, 2014
82. Dunn BK, Richmond ES, Minasian LM, Ryan AM, and Ford LG A nutrient approach to prostate cancer prevention: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Nutr Cancer 62: 896-918, 2010
83. El Midaoui A and de Champlain J. Prevention of hypertension, insulin resistance, and oxidative stress by alphalipoic acid. Hypertension 39: 303-307, 2002
84. Esplugues JV, Rocha M, Nuñez C, Bosca I, Ibiza S, Herance JR, Ortega A, Serrador JM, DOcon P, and Victor VM.complex I dysfunction and tolerance to nitroglycerin: an approach based on mitochondrial-Targeted antioxidants. Circ Res 99: 1067-1075, 2006
85. Fariss MW, Chan CB, Patel M, Van Houten B, and Orrenius S. Role of mitochondria in toxic oxidative stress. Cationic antioxidants as a powerful tool against mitochondrial oxidative stress. Mol Interv 5: 94-111, 2005
86. Farrow KN, Lee KJ, Perez M, Schriewer JM, Wedgwood S, Lakshminrusimha S, Smith CL, Steinhorn RH, and Schumacker PT. Brief hyperoxia increases mitochondrial oxidation and increases phosphodiesterase 5 activity in fetal pulmonary artery smooth muscle cells. Antioxid Redox Signal 17: 460-470, 2012
87. Fauconnier J, Meli AC, Thireau J, Roberge S, Shan J, Sassi Y, Reiken SR, Rauzier JM, Marchand A, Chauvier D, Cassan C, Crozier C, Bideaux P, Lompré AM, Jacotot E, Marks AR, and Lacampagne A. Ryanodine receptor leak mediated by caspase-8 activation leads to left ventricular injury after myocardial ischemia-reperfusion. Proc Natl Acad Sci U S A 108: 13258-13263, 2011
88. Ferrer-Sueta G, Hannibal L, Batinic-Haberle I, and Radi R. Reduction of manganese porphyrins by flavoenzymes and submitochondrial particles: a catalytic cycle for the reduction of peroxynitrite. Free Radic Biol Med 41: 503-512, 2006
89. Fetisova EK, Avetisyan AV, Izyumov DS, Korotetskaya MV, Chernyak BV, and Skulachev VP. Mitochondriatargeted antioxidant SkQR1 selectively protects MDR (Pgp 170)-negative cells against oxidative stress. FEBS Lett 584: 562-566, 2010
90. Fialkow L, Wang Y, and Downey GP. Reactive oxygen and nitrogen species as signaling molecules regulating neutrophil function. Free Radic Biol Med 42: 153-164, 2007
91. Filipovska A, Kelso GF, Brown SE, Beer SM, Smith RA, and Murphy MP. Synthesis and characterization of a triphenylphosphonium-conjugated peroxidase mimetic. Insights into the interaction of ebselen with mitochondria. J Biol Chem 280: 24113-24126, 2005.
92. Fink BD, Herlein JA, Yorek MA, Fenner, Kerns RJ, and Sivitz WI. Bioenergetic effects of mitochondrial-Targeted coenzyme Q analogs in endothelial cells. JPET 342: 709-719, 2012
93. Fink MP, Macias CA, Xiao J, Tyurina YY, Delude RL, Greenberger JS, Kagan VE, and Wipf P. Hemigramicidin-TEMPO conjugates: novel mitochondria-Targeted antioxidants. Crit Care Med 35: 461-467, 2007
94. Fransen M, Nordgren M, Wang B, and Apanasets O. Role of peroxisomes in ROS/RNS-metabolism: implications for human disease. Biochim Biophys Acta 1822: 1363-1373, 2012
95. Frantz MC and Wipf P. Mitochondria as a target in treatment. Environ Mol Mutagen 51: 462-475, 2010
96. Garcia-Bou R, Rocha M, Apostolova N, Herance R, Hernandez-Mijares A, and Victor VM. Evidence for a relationship between mitochondrial complex I activity and mitochondrial aldehyde dehydrogenase during nitroglycerin tolerance: effects of mitochondrial antioxidants. Biochim Biophys Acta 1817: 828-837, 2012
97. Geisler S, Holmstrom KM, Skujat D, Fiesel FC, Rothfuss OC, Kahle PJ, and Springer W. PINK1/Parkin-mediated mitophagy is dependent on VDAC1 and p62/SQSTM1. Nat Cell Biol 12: 119-131, 2010
98. Gibson KR, Winterburn TJ, Barrett F, Sharma S, MacRury S, and Megson IL. Therapeutic potential of N-Acetylcysteine as an antiplatelet agent in patients with type-2 diabetes. Cardiovasc Diabetol 10: 1-8, 2011
99. Gioscia-Ryan RA, LaRocca TJ, Sindler AL, Zigler MC, Murphy MP, and Seals DR. Mitochondria-Targeted antioxidant (MitoQ) ameliorates age-related arterial endothelial dysfunction in mice. J Physiol 592: 2549-2561, 2014
100. Gladwin MT and Shiva S. The ligand binding battle at cytochrome c oxidase: how NO regulates oxygen gradients in tissue. Circ Res 104: 1136-1138, 2009
101. Gomes A, Costa D, Lima JL, and Fernandes E. Antioxidant activity of beta-blockers: an effect mediated by scavenging reactive oxygen and nitrogen species?. Bioorg Med Chem 14: 4568-4577, 2006
102. Gomes LC and Scorrano L. High levels of Fis1, a profission mitochondrial protein, trigger autophagy. Biochim Biophys Acta 1777: 860-866, 2008
103. Goodman GE, Thornquist MD, Balmes J, Cullen MR, Meyskens FL, Jr., Omenn GS, Valanis B, and Williams JH, Jr. The Beta-Carotene and Retinol Efficacy Trial: incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. J Natl Cancer Inst 96: 1743-1750, 2004
104. Goraca A, Huk-Kolega H, Piechota A, Kleniewska P, Ciejka E, and Skibska B. Lipoic acid-biological activity and therapeutic potential. Pharmacol Rep 63: 849-858, 2011
105. Graham D, Huynh NN, Hamilton CA, Beattie E, Smith RA, Cochemé HM, Murphy MP, and Dominiczak AF. Mitochondria-Targeted antioxidant MitoQ10 improves endothelial function and attenuates cardiac hypertrophy. Hypertension 54: 322-328, 2009
106. Gray KM, Watson NL, Carpenter MJ, and LaRowe SD. N-Acetylcysteine (NAC) in young marijuana users: an open-label pilot study. Am J Addict 19: 187-189, 2010
107. Gruber J, Fong S, Chen CB, Yoong S, Pastorin G, Schaffer S, Cheah I, and Halliwell B. Mitochondriatargeted antioxidants and metabolic modulators as pharmacological interventions to slow ageing. Biotechnol Adv 31: 563-592, 2013
108. Gründemann D, Harlfinger S, Golz S, Geerts A, Lazar A, Berkels R, Jung N, Rubbert A, and Schömig E. Discovery of the ergothioneine transporter. Proc Natl Acad Sci U S A 102: 5256-5261, 2005
109. Grundlingh J, Dargan PI, El-Zanfaly M, and Wood DM. 2, 4-Dinitrophenol (DNP): a weight loss agent with significant acute toxicity and risk of death. J Med Toxicol 7: 205-212, 2011
110. Hagen TM, Ingersoll RT, Lykkesfeldt J, Liu J, Wehr CM, Vinarsky V, Bartholomew JC, and Ames AB. (R)-Alphalipoic acid-supplemented old rats have improved mitochondrial function, decreased oxidative damage, and increased metabolic rate. FASEB J 13: 411-418, 1999
111. Hagen TM, Liu J, Lykkesfeldt J, Wehr CM, Ingersoll RT, Vinarsky V, Bartholomew JC, and Ames BN. Feeding acetyl-L-carnitine and lipoic acid to old rats significantly improves metabolic function while decreasing oxidative stress. Proc Natl Acad Sci U S A 99: 1870-1875, 2002
112. Haines DD, Lekli I, Teissier P, Bak I, and Tosaki A. Role of haeme oxygenase-1 in resolution of oxidative stressrelated pathologies: focus on cardiovascular, lung, neurological and kidney disorders. Acta Physiol (Oxf) 204: 487-501, 2012
113. Haines TH and Dencher NA. Cardiolipin: a proton trap for oxidative phosphorylation. FEBS Lett 528: 35-39, 2002
114. Halliwell B and Gutteridge JMC. Free Radicals in Biology and Medicine, 4th edition. Oxford, NY. Oxford University Press, 2007
115. Han XJ, Lu YF, Li SA, Kaitsuka T, Sato Y, Tomizawa K, Nairn AC, Takei K, Matsui H, and Matsushita M. CaM kinase I alpha-induced phosphorylation of Drp1 regulates mitochondrial morphology. J Cell Biol 182: 573-585, 2008
116. Hansen JM, Zhang H, and Jones DP. Mitochondrial thioredoxin-2 has a key role in determining tumor necrosis factor-Alpha-induced reactive oxygen species generation, NF-kappaB activation, and apoptosis. Toxicol Sci 91: 643-650, 2006
117. Haramaki N, Han D, Handelman GJ, Tritschler HJ, and Packer L. Cytosolic and mitochondrial systems for NADH-And NADPH-dependent reduction of alpha-lipoic acid. Free Radic Biol Med 22: 535-542, 1997
118. Harman D. Aging: a theory based on free radical and radiation chemistry. J Gerontol 11: 298-300, 1956
119. Hausse AO, Aggoun Y, Bonnet D, Sidi D, Munnich A, Rötig A, and Rustin P. Idebenone and reduced cardiac hypertrophy in Friedreichs ataxia. Heart 87: 346-349, 2002
120. He C, Zhu H, Li H, Zou MH, and Xie Z. Dissociation of Bcl-2-Beclin1 complex by activated AMPK enhances cardiac autophagy and protects against cardiomyocyte apoptosis in diabetes. Diabetes 62: 1270-1281, 2013
121. Herbert V, Shaw S, and Jayatilleke E. Vitamin C-driven free radical generation from iron. J Nutr 126: 1213S-1220S, 1996
122. Higashida K, Kim SH, Jung SR, Asaka M, Holloszy JO, and Han DH. Effects of resveratrol and SIRT1 on PGC-1alpha activity and mitochondrial biogenesis: a reevaluation. PLoS Biol 11: e1001603, 2013
123. Hood E, Simone E, Wattamwar P, Dziubla T, and Muzykantov V. Nanocarriers for vascular delivery of antioxidants. Nanomedicine (Lond) 6: 1257-1272, 2011
124. Horke S, Witte I, Wilgenbus P, Kruger M, Strand D, and Forstermann U. Paraoxonase-2 reduces oxidative stress in vascular cells and decreases endoplasmic reticulum stressinduced caspase activation. Circulation 115: 2055-2064, 2007
125. Horton KL, Stewart KM, Fonseca SB, Guo Q, and Kelley SO. Mitochondria-penetrating peptides. Chem Biol 15: 375-382, 2008
126. Hoth M, Fanger CM, and Lewis RS. Mitochondrial regulation of store operated calcium signaling in T lymphocytes. J Cell Biol 137: 633-648, 1997
127. Ishihara N, Jofuku A, Eura Y, and Mihara K. Regulation of mitochondrial morphology by membrane potential, and DRP1-dependent division and FZO1-dependent fusion reaction in mammalian cells. Biochem Biophys Res Commun 301: 891-898, 2003
128. Itoh T, Fairall L, Amin K, Inaba Y, Szanto A, Balint BL, Nagy L, Yamamoto K, and Schwabe JW. Structural basis for the activation of PPARgamma by oxidized fatty acids. Nat Struct Mol Biol 15: 924-931, 2008
129. Jackson MJ, Pye D, and Palomero J. The production of reactive oxygen and nitrogen species by skeletal muscle. J Appl Physiol 102: 1664-1670, 2007
130. James AM, Smith RA, and Murphy MP. Antioxidant and prooxidant properties of mitochondrial Coenzyme Q. Arch Biochem Biophys 423: 47-56, 2004
131. James DI, Parone PA, Mattenberger Y, and Martinou JC. hFis1, a novel component of the mammalian mitochondrial fission machinery. J Biol Chem 278: 36373-36379, 2003
132. Jauslin ML, Meier T, Smith RA, and Murphy MP. Mitochondria-Targeted antioxidants protect Friedreich Ataxia fibroblasts from endogenous oxidative stress more effectively than untargeted antioxidants. FASEB J 17: 1972-1974, 2003
133. Jiang J, Belikova NA, Hoye AT, Zhao Q, Epperly MW, Greenberger JS, Wipf P, and Kagan VE A mitochondriatargeted nitroxide/hemigramicidin S conjugate protects mouse embryonic cells against gamma irradiation. Int J Radiat Oncol Biol Phys 70: 816-825, 2008
134. Jiang J, Kurnikov I, Belikova NA, Xiao J, Zhao Q, Amoscato AA, Braslau R, Studer A, Fink MP, Greenberger JS, Wipf P, and Kagan VE. Structural requirements for optimized delivery, inhibition of oxidative stress, and antiapoptotic activity of targeted nitroxides. J Pharmacol Exp Ther 320: 1050-1060, 2007
135. Jin SM, Lazarou M, Wang C, Kane LA, Narendra DP, and Youle RJ. Mitochondrial membrane potential regulates PINK1 import and proteolytic destabilization by PARL. J Cell Biol 191: 933-942, 2010
136. Jones DP and Go YM. Redox compartmentalization and cellular stress. Diabetes Obes Metab 12: 116-125, 2010
137. Judé S, Bedut S, Roger S, Pinault M, Champeroux P, White E, and Le Guennec JY. Peroxidation of docosahexaenoic acid is responsible for its effects on I TO and I SS in ratventricular myocytes. Br J Pharmacol 139: 816-822, 2003
138. Jung C, Rong Y, Doctrow S, Baudry M, Malfroy B, and Xu Z. Synthetic superoxide dismutase/catalase mimetics reduce oxidative stress and prolong survival in a mouse amyotrophic lateral sclerosis model. Neurosci Lett 304: 157-160, 2001
139. Kanki T, Nakayama H, Sasaki N, Takio K, Alam TI, Hamasaki N, and Kang D. Mitochondrial nucleoid and transcription factor A. Ann N Y Acad Sci 1011: 61-68, 2004
140. Kaneto H, Kajimoto Y, Miyagawa J, Matsuoka T, Fujitani Y, Umayahara Y, Hanafusa T, Matsuzawa Y, Yamasaki Y, and Hori M. Beneficial effects of antioxidants in diabetes: possible protection of pancreatic beta-cells against glucose toxicity. Diabetes 48: 2398-2406, 1999
141. Kapay NA, Popova OV, Isaev NK, Stelmashook EV, Kondratenko RV, Zorov DB, Skrebitsky VG, and Skulachev VP. Mitochondria-Targeted plastoquinone antioxidant SkQ1 prevents amyloid-b-induced impairment of long-Term potentiation in rat hippocampal slices. J Alzheimers Dis 36: 377-383, 2013
142. Kawano H, Otani M, Takeyama K, Kawai Y, Mayumi T, and Hama T. Studies on ergothioneine. VI. Distribution and fluctuations of ergothioneine in rats. Chem Pharm Bull (Tokyo) 30: 1760-1765, 1982
143. Kelley DE and Goodpaster BH. Effects of physical activity on insulin action and glucose tolerance in obesity. Med Sci Sports Exerc 31: S619-S623, 1999
144. Kelso GF, Porteous CM, Coulter CV, Hughes G, Porteous WK, Ledgerwood EC, Smith RA, and Murphy MP. Selective targeting of a redox-Active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J Biol Chem 276: 4588-4596, 2001
145. Khalil IA, Kogure K, Futaki S, and Harashima H. High density of octaarginine stimulates macropinocytosis leading to efficient intracellular trafficking for gene expression. J Biol Chem 281: 3544-3551, 2006
146. Kiffin R, Bandyopadhyay U, and Cuervo AM. Oxidative stress and autophagy. Antioxid Redox Signal 8: 152-162, 2006
147. Kim J, Kundu M, Viollet B, and Guan KL. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1. Nat Cell Biol 13: 132-141, 2011
148. Kim H, Lee TH, Hwang YS, Bang MA, Kim KH, Suh JM, Chung HK, Yu DY, Lee KK, Kwon OY, Ro HK, and Shong M. Methimazole as an antioxidant and immunomodulator in thyroid cells: mechanisms involving interferon-gamma signaling and H(2)O(2) scavenging. Mol Pharmacol 60: 972-980, 2001
149. Kissova I, Deffieu M, Manon S, and Camougrand N. Uth1p is involved in the autophagic degradation of mitochondria. J Biol Chem 279: 39068-39074, 2004
150. Klopstock T, Metz G, Yu-Wai-Man P, Büchner B, Gallenmüller C, Bailie M, Nwali N, Griffiths PG, von Livonius B, Reznicek L, Rouleau J, Coppard N, Meier T, and Chinnery PF. Persistence of the treatment effect of idebenone in Lebers hereditary optic neuropathy. Brain 136: e230, 2013
151. Knackstedt LA, LaRowe S, Mardikian P, Malcolm R, Upadhyaya H, Hedden S, Markou A, and Kalivas PW. The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biol Psychiatry 65: 841-845, 2009
152. Kogure K, Akita H, Yamada Y, and Harashima H. Multifunctional envelope-Type nano device (MEND) as a nonviral gene delivery system. Adv Drug Deliv Rev 60: 559-571, 2008
153. Kong W, Chen LL, Zheng J, Zhang HH, Hu X, Zeng TS, and Hu D. Resveratrol supplementation restores high-fat diet-induced insulin secretion dysfunction by increasing mitochondrial function in islet. Exp Biol Med 2014 [Epub ahead of print]; pii: 1535370214548998
154. Koopman WJ, Verkaart S, Visch HJ, van der Westhuizen FH, Murphy MP, van den Heuvel LW, Smeitink JA, and Willems PH. Inhibition of complex I of the electron transport chain causes O2-mediated mitochondrial outgrowth. Am J Physiol Cell Physiol 288: 1440-1450, 2005
155. Koshiba T, Detmer SA, Kaiser JT, Chen H, McCaffery JM, and Chan DC. Structural basis of mitochondrial tethering by mitofusin complexes. Science 305: 858-862, 2004
156. Kröller-Schön S, Jansen T, Schüler A, Oelze M, Wenzel P, Hausding M, Kerahrodi JG, Beisele M, Lackner KJ, Daiber A, Münzel T, and Schulz E. Peroxisome proliferatoractivated receptor c, coactivator 1a deletion induces angiotensin II-Associated vascular dysfunction by increasing mitochondrial oxidative stress and vascular inflammation. Arterioscler Thromb Vasc Biol 33: 1928-1935, 2013
157. Kumar KV, Shifow AA, Naidu MU, and Ratnakar KS. Carvedilol: a beta blocker with antioxidant property protects against gentamicin-induced nephrotoxicity in rats. Life Sci 66: 2603-2611, 2000
158. Lafleur DL, Pittenger C, Kelmendi B, Gardner T, Wasylink S, Malison RT, Sanacora G, Krystal JH, and Coric V. N-Acetylcysteine augmentation in serotonin reuptake inhibitor refractory obsessive-compulsive disorder. Psychopharmacology (Berl) 184: 254-256, 2006
159. Lamhonwah AM and Tein I. Novel localization of OCTN1, an organic cation/carnitine transporter, to mammalian mitochondria. Biochem Biophys Res Commun 345: 1315-1325, 2006
160. Langan AR, Khan MA, Yeung IW, Van Dyk J, and Hill RP. Partial volume rat lung irradiation: the protective/mitigating effects of Eukarion-189, a superoxide dismutase-catalase mimetic. Radiother Oncol 79: 231-238, 2008
161. Lavoie S, Murray MM, Deppen P, Knyazeva MG, Berk M, Boulat O, Bovet P, Bush AI, Conus P, Copolov D, Fornari E, Meuli R, Solida A, Vianin P, Cuénod M, Buclin T, and Do KQ. Glutathione precursor, N-Acetyl-cysteine, improves mismatch negativity in schizophrenia patients. Neuropsychopharmacology 33: 2187-2199, 2008
162. Lee JH, Kim B, Jin WJ, Kim JW, Kim HH, Ha H, and Lee ZH. Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms. Biochem Pharmacol 91: 51-60, 2014
163. Lee SM and Cho TS. Effect of Trolox on hypoxia/reoxygenation-induced injury in isolated perfused rat liver. Arch Pharm Res 20: 471-475, 1997
164. Lee TM, Lin SZ, and Chang NC. Both PKA and Epac pathways mediate N-Acetylcysteine-induced Connexin43 preservation in rats with myocardial infarction. PLoS One 8: e71878, 2013
165. Lemasters JJ. Selective mitochondrial autophagy, or mitophagy, as a targeted defense against oxidative stress, mitochondrial dysfunction, and aging. Rejuvenation Res 8: 3-5, 2005
166. Lemire BD, Behrendt M, DeCorby A, and Gásková D. C. elegans longevity pathways converge to decrease mitochondrial membrane potential. Mech Ageing Dev 130: 461-465, 2009
167. Leo S, Szabadkai G, and Rizzuto R. The mitochondrial antioxidants MitoE(2) and MitoQ(10) increase mitochondrial Ca(2 + ) load upon cell stimulation by inhibiting Ca(2 + ) efflux from the organelle. Ann N Y Acad Sci 1147: 264-274, 2008
168. Leus FR, Zwart M, Kastelein JJ, and Voorbij HA. PON2 gene variants are associated with clinical manifestations of cardiovascular disease in familial hypercholesterolemia patients. Atherosclerosis 154: 641-649, 2001
169. Li J, Chen X, Xiao W, Ma W, Li T, Huang J, Liu X, Liang X, Tang S, and Luo Y. Mitochondria-Targeted antioxidant peptide SS31 attenuates high glucose-induced injury on human retinal endothelial cells. Biochem Biophys Res Commun 404: 349-356, 2011
170. Li H, Xia N, and Förstermann U. Cardiovascular effects and molecular targets of resveratrol. Nitric Oxide 26: 102-110, 2012
171. Lim S, Rashid MA, Jang M, Kim Y, Won H, Lee J, Woo JT, Kim YS, Murphy MP, Ali L, Ha J, and Kim SS. Mitochondria-Targeted antioxidants protect pancreatic bcells against oxidative stress and improve insulin secretion in glucotoxicity and glucolipotoxicity. Cell Physiol Biochem 28: 873-886, 2011
172. Linker RA, Lee DH, Ryan S, van Dam AM, Conrad R, Bista P, Zeng W, Hronowsky X, Buko A, Chollate S, Ellrichmann G, Brück W, Dawson K, Goelz S, Wiese S, Scannevin RH, Lukashev M, and Gold R. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 134: 678-692, 2011
173. Lipinski CA, Lombardo F, Dominy BW, and Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev 46: 3-26, 2001
174. Liu R, Liu IY, Bi X, Thompson RF, Doctrow SR, Malfroy B, and Baudry M. Reversal of age-related learning deficits and brain oxidative stress in mice with superoxide dismutase/catalase mimetics. Proc Natl Acad Sci U S A 100: 8526-8531, 2003
175. Liu S, Soong Y, Seshan SV, and Szeto HH. Novel cardiolipin therapeutic protects endothelial mitochondria during renal ischemia and mitigates microvascular rarefaction, inflammation and fibrosis. Am J Physiol Renal Physiol 306: 970-980, 2014
176. Lloret A, Badía MC, Mora NJ, Pallardó FV, Alonso MD, and Viña J. Vitamin E paradox in Alzheimers disease: it does not prevent loss of cognition and may even be detrimental. J Alzheimers Dis 17: 143-149, 2009
177. Loguercio C, Federico A, Trappoliere M, Tuccillo C, de Sio I, Di Leva A, Niosi M, DAuria MV, Capasso R, Del Vecchio Blanco C, and Real Sud Group. The effect of a silybin-vitamin e-phospholipid complex on nonalcoholic fatty liver disease: a pilot study. Dig Dis Sci 52: 2387-2395, 2007
178. Lonn E, Yusuf S, Hoogwerf B, Pogue J, Yi Q, Zinman B, Bosch J, Dagenais G, Mann JF, and Gerstein HC. Effects of vitamin E on cardiovascular and microvascular outcomes in high-risk patients with diabetes: results of the HOPE study and MICRO-HOPE substudy. Diabetes Care 25: 1919-1927, 2002
179. Lou PH, Hansen BS, Olsen PH, Tullin S, Murphy MP, and Brand MD. Mitochondrial uncouplers with an extraordinary dynamic range. Biochem J 407: 129-140, 2007
180. Lowes DA, Thottakam BM, Webster NR, Murphy MP, and Galley HF. The mitochondria-Targeted antioxidant MitoQ protects against organ damage in a lipopolysaccharide-peptidoglycan model of sepsis. Free Radic Biol Med 45: 1559-1565, 2008
181. Lu L, Erhard P, Salomon RG, and Weiss MF. Serum vitamin E and oxidative protein modification in hemodialysis: a randomized clinical trial. Am J Kidney Dis 50: 305-313, 2007
182. Ma T, Hoeffer CA, Wong H, Massaad CA, Zhou P, Iadecola C, Murphy MP, Pautler RG, and Klann E. Amyloid b-induced impairments in hippocampal synaptic plasticity are rescued by decreasing mitochondrial superoxide. J Neurosci 31: 5589-5595, 2011
183. Macias CA, Chiao JW, Xiao J, Arora DS, Tyurina YY, Delude RL, Wipf P, Kagan VE, and Fink MP. Treatment with a novel hemigramicidin-TEMPO conjugate prolongs survival in a rat model of lethal hemorrhagic shock. Ann Surg 245: 305-314, 2007
184. Mackenzie RM, Salt IP, Miller WH, Logan A, Ibrahim HA, Degasperi A, Dymott JA, Hamilton CA, Murphy MP, Delles C, and Dominiczak AF. Mitochondrial reactive oxygen species enhance AMP-Activated protein kinase activation in the endothelium of patients with coronary artery disease and diabetes. Clin Sci (Lond) 124: 403-411, 2013
185. Mafra D Santos FR, Lobo JC, de Mattos Grosso D, Barreira AL, Velarde LG, Abdalla DS, and Leite M, Jr. Alpha-Tocopherol supplementation decreases electronegative low-density lipoprotein concentration [LDL(-)] in haemodialysis patients. Nephrol Dial Transplant 24: 1587-1592, 2009
186. Makino A, Scott BT, and Dillmann WH. Mitochondrial fragmentation and superoxide anion production in coronary endothelial cells from a mouse model of type 1 diabetes. Diabetologia 53: 1783-1794, 2010
187. Manczak M, Mao P, Calkins MJ, Cornea A, Reddy AP, Murphy MP, Szeto HH, Park B, and Reddy PH. Mitochondria-Targeted antioxidants protect against amyloidb toxicity in Alzheimers disease neurons. J Alzheimers Dis 20: S609-S631, 2010
188. Maroz A, Anderson RF, Smith RA, and Murphy MP. Reactivity of ubiquinone and ubiquinol with superoxide and the hydroperoxyl radical: implications for in vivo antioxidant activity. Free Radic Biol Med 46: 105-109, 2009
189. Marrache S and Dhar S. Engineering of blended nanoparticle platform for delivery of mitochondria-Acting therapeutics. Proc Natl Acad Sci U S A 109: 16288-16293, 2012
190. Martin LJ. Biology of mitochondria in neurodegenerative diseases. Prog Mol Biol Transl Sci 107: 355-415, 2012
191. Martina V, Masha A, Gigliardi VR, Brocato L, Manzato E, Berchio A, Massarenti P, Settanni F, Della Casa L, Bergamini S, and Iannone A. Long-Term N-Acetylcysteine and L-Arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes. Diabetes Care 31: 940-944, 2008
192. Mason MG, Nicholls P, Wilson MT, and Cooper CE. Nitric oxide inhibition of respiration involves both competitive (heme) and noncompetitive (copper) binding to cytochrome c oxidase. Proc Natl Acad Sci U S A 103: 708-713, 2006
193. McClung JM, Judge AR, Powers SK, and Yan Z. p38 MAPK links oxidative stress to autophagy-related gene expression in cachectic muscle wasting. Am J Physiol Cell Physiol 298: C542-C549, 2010
194. McLachlan J, Beattie E, MurphyMP, Koh-Tan CH, Olson E, Beattie W, Dominiczak AF, Nicklin SA, and Graham D.combined therapeutic benefit of mitochondria-Targeted antioxidant, MitoQ10, and angiotensin receptor blocker, losartan, on cardiovascular function. J Hypertens 32: 555-564, 2014
195. Meagher EA, Barry OP, Lawson JA, Rokach J, and FitzGerald GA. Effects of vitamin E on lipid peroxidation in healthy persons. JAMA 285: 1178-1182, 2001
196. Melov S, Coskun P, Patel M, Tuinstra R, Cottrell B, Jun AS, Zastawny TH, Dizdaroglu M, Goodman SI, Huang TT, Miziorko H, Epstein CJ, and Wallace DC. Mitochondrial disease in superoxide dismutase 2 mutant mice. Proc Natl Acad Sci U S A 96: 846-851, 1999
197. Melov S, Doctrow SR, Schneider JA, Haberson J, Patel M, Coskun PE, Huffman K, Wallace DC, and Malfroy B. Lifespan extension and rescue of spongiform encephalopathy in superoxide dismutase 2 nullizygous mice treated with superoxide dismutase-catalase mimetics. J Neurosci 21: 8348-8353, 2001
198. Melov S, Wolf N, Strozyk D, Doctrow SR, and Bush AI. Mice transgenic for Alzheimer disease beta-Amyloid develop lens cataracts that are rescued by antioxidant treatment. Free Radic Biol Med 38: 258-261, 2005
199. Mercer JR, Yu E, Figg N, Cheng KK, Prime TA, Griffin JL, Masoodi M, Vidal-Puig A, Murphy MP, and Bennett MR. The mitochondria-Targeted antioxidant MitoQ decreases features of the metabolic syndrome in ATM+/-/ApoE-/-mice. Free Radic Biol Med 52: 841-849, 2012
200. Miranda-Massari JR, Gonzalez MJ, Jimenez FJ, Allende-Vigo MZ, and Duconge J. Metabolic correction in the management of diabetic peripheral neuropathy: improving clinical results beyond symptom Control. Curr Clin Pharmacol 6: 260-273, 2011
201. Miriyala S, Spasojevic I, Tovmasyan A, Salvemini D, Vujaskovic Z, St. Clair D, and Batinic-Haberle I. Manganese superoxide dismutase, MnSOD and its mimics. Biochim Biophys Acta 1822: 794-814, 2012
202. Mizuguchi Y, Chen J, Seshan SV, Poppas DP, Szeto HH, and Felsen D A novel cell-permeable antioxidant peptide decreases renal tubular apoptosis and damage in unilateral ureteral obstruction. Am J Physiol Renal Physiol 295: 1545-1553, 2008
203. Mizushima N. Autophagy: process and function. Genes Dev 21: 2861-2873, 2007
204. Mizushima N, Levine B, Cuervo AM, and Klionsky DJ. Autophagy fights disease through cellular self-digestion. Nature 451: 1069-1075, 2008
205. Mochizuki M, Yano M, Oda T, Tateishi H, Kobayashi S, Yamamoto T, Ikeda Y, Ohkusa T, Ikemoto N, and Matsuzaki M. Scavenging free radicals by low-dose carvedilol prevents redoxdependent Ca2 + leak viastabilization of ryanodine receptor in heart failure. J Am Coll Cardiol 49: 1722-1732, 2007
206. Moreira PI, Harris PL, Zhu X, Santos MS, Oliveira CR, Smith MA, and Perry G. Lipoic acid and N-Acetyl cysteine decrease mitochondrial-related oxidative stress in Alzheimer disease patient fibroblasts. J Alzheimers Dis 12: 195-206, 2007
207. Moreira PI, Santos MS, Sena C, Nunes E, Seiça R, and Oliveira CR. CoQ10 therapy attenuates amyloid betapeptide toxicity in brain mitochondria isolated from aged diabetic rats. Exp Neurol 196: 112-119, 2005
208. Morris MC and Tangney CC A potential design flaw of randomized trials of vitamin supplements. JAMA 305: 1348-1349, 2011
209. Murphy MP, Echtay KS, Blaikie FH, Asin-Cayuela J, Cocheme HM, Green K, Buckingham JA, Taylor ER, Hurrell F, Hughes G, Miwa S, Cooper CE, Svistunenko DA, Smith RA, and Brand MD. Superoxide activates uncoupling proteins by generating carbon-centered radicals and initiating lipid peroxidation: studies using a mitochondria-Targeted spin trap derived from alpha-phenyl-Ntert-butylnitrone. J Biol Chem 278: 48534-48545, 2003
210. Murphy MP and Smith RA. Drug delivery to mitochondria: the key to mitochondrial medicine. Adv Drug Deliv Rev 41: 235-250, 2000
211. Murphy MP and Smith RA. Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu Rev Pharmacol Toxicol 47: 629-656, 2007
212. Musatov A and Robinson NC. Susceptibility of mitochondrial electron-Transport complexes to oxidative damage. Focus on cytochrome c oxidase. Free Radic Res 46: 1313-1326, 2012
213. Naon D and Scorrano L. At the right distance: ER-mitochondria juxtaposition in cell life and death. Biochim Biophys Acta 1843: 2184-2194, 2014
214. Narendra DP, Jin SM, Tanaka A, Suen DF, Gautier CA, Shen J, Cookson MR, and Youle RJ. PINK1 is selectively stabilized on impaired mitochondria to activate Parkin. PLoS Biol 8: e1000298, 2010
215. Navarro-Sastre A, Tort F, Stehling O, Uzarska MA, Arranz JA, Del Toro M, Labayru MT, Landa J, Font A, Garcia-Villoria J, Merinero B, Ugarte M, Gutierrez-Solana LG, Campistol J, Garcia-Cazorla A, Vaquerizo J, Riudor E, Briones P, Elpeleg O, Ribes A, and Lill R A fatal mitochondrial disease is associated with defective NFU1 function in the maturation of a subset of mitochondrial Fe-S proteins. Am J Hum Genet 89: 656-667, 2011
216. Nishida K, Yamaguchi O, and Otsu K. Crosstalk between autophagy and apoptosis in heart disease. Circ Res 103: 343-351, 2008
217. Nisoli E, Clementi E, Paolucci C, Cozzi V, Tonello C, Sciorati C, Bracale R, Valerio A, Francolini M, Moncada S, and Carruba MO. Mitochondrial biogenesis in mammals: the role of endogenous nitric oxide. Science 299: 896-899, 2003
218. Nisoli E, Tonello C, Cardile A, Cozzi V, Bracale R, Tedesco L, Falcone S, Valerio A, Cantoni O, Clementi E, Moncada S, and Carruba MO. Calorie restriction promotes mitochondrial biogenesis by inducing the expression of eNOS. Science 310: 314-317, 2005
219. Ojala D, Montoya J, and Attardi G. tRNA punctuation model of RNA processing in human mitochondria. Nature 290: 470-474, 1981
220. Okada K, Wangpoengtrakul C, Osawa T, Toyokuni S, Tanaka K, and Uchida K. 4-Hydroxy-2-nonenal-mediated impairment of intracellular proteolysis during oxidative stress. Identification of proteasomes as target molecules. J Biol Chem 274: 23787-23793, 1999
221. Olichon A, Baricault L, Gas N, Guillou E, Valette A, Belenguer P, and Lenaers G. Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis. J Biol Chem 278: 7743-7746, 2003
222. Olichon A, Elachouri G, Baricault L, Delettre C, Belenguer P, and Lenaers G. OPA1 alternate splicing uncouples an evolutionary conserved function in mitochondrial fusion from a vertebrate restricted function in apoptosis. Cell Death Differ 14: 682-692, 2007
223. Oliveira PJ, Seica R, Santos DL, Rolo AP, Sardao VA, Ferreira FM, Palmeira CM, Santos MS, and Moreno AJ. Vitamin E or coenzyme Q10 administration is not fully advantageous for heart mitochondrial function in diabetic goto kakizaki rats. Mitochondrion 3: 337-345, 2004
224. Olson KR. Hydrogen sulfide is an oxygen sensor in the carotid body. Respir Physiol Neurobiol 179: 103-110, 2011
225. Olson KR and Whitfield NL. Hydrogen sulfide and oxygen sensing in the cardiovascular system. Antioxid Redox Signal 12: 1219-1234, 2010
226. Omarova EO and Antonenko YN. Inhibition of oxidative hemolysis in erythrocytes by mitochondria-Targeted antioxidants of SkQ series. Biochemistry (Mosc) 79: 139-145, 2014
227. Omaye ST, Krinsky NI, Kagan VE, Mayne ST, Liebler DC, and Bidlack WR. beta-carotene: friend or foe? Fundam Appl Toxicol 40: 163-174, 1997
228. Oyewole AO, Wilmot MC, Fowler M, and Birch-Machin MA.comparing the effects of mitochondrial targeted and localized antioxidants with cellular antioxidants in human skin cells exposed to UVA and hydrogen peroxide. FASEB J 28: 485-494, 2014
229. Pan XR, Li GW, Hu YH, Wang JX, Yang WY, An ZX, Hu ZX, Lin J, Xiao JZ, Cao HB, Liu PA, Jiang XG, Jiang YY, Wang JP, Zheng H, Zhang H, Bennett PH, and Howard BV. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 20: 537-544, 12997
230. Papparella I, Ceolotto G, Berto L, Cavalli M, Bova S, Cargnelli G, Ruga E, Milanesi O, Franco L, Mazzoni M, Petrelli L, Nussdorfer GG, and Semplicini A. Vitamin C prevents zidovudine-induced NAD(P)H oxidase activation and hypertension in the rat. Cardiovasc Res 73: 432-438, 2007
231. Patková J, Anděl M, and Trnka J. Palmitate-induced cell death and mitochondrial respiratory dysfunction in myoblasts are not prevented by mitochondria-Targeted antioxidants. Cell Physiol Biochem 33: 1439-1451, 2014
232. Patra SK, Singh K, and Singh R. Paraoxonase 1: a better atherosclerotic risk predictor than HDL in type 2 diabetes mellitus. Diabetes Metab Syndr 7: 108-111, 2013
233. Paul BD and Snyder SH. The unusual amino acid Lergothioneine is a physiologic cytoprotectant. Cell Death Differ 17: 1134-1140, 2010
234. Pauly M, Daussin F, Burelle Y, Li T, Godin R, Fauconnier J, Koechlin-Ramonatxo C, Hugon G, Lacampagne A, Coisy-Quivy M, Liang F, Hussain S, Matecki S, and Petrof BJ. AMPK activation stimulates autophagy and ameliorates muscular dystrophy in the mdx mouse diaphragm. Am J Pathol 181: 583-592, 2012
235. Peng J, Stevenson FF, Doctrow SR, and Andersen JK. Superoxide dismutase/catalase mimetics are neuroprotective against selective paraquat-mediated dopaminergic neuron death in the substantial nigra: implications for Parkinson disease. J Biol Chem 280: 29194-29198, 2005
236. Persson MF, Franzen S, Catrina SB, Dallner G, Hansell P, Brismar K, and Palm F. Coenzyme Q10 prevents GDPsensitive mitochondrial uncoupling, glomerular hyperfiltration and proteinuria in kidneys from db/db mice as a model of type 2 diabetes. Diabetologia 55: 1535-1543, 2012
237. Petri S, Kiaei M, Damiano M, Hiller A, Wille E, Manfredi G, Calingasan NY, Szeto HH, and Beal MF. Cellpermeable peptide antioxidants as a novel therapeutic approach in a mouse model of amyotrophic lateral sclerosis. J Neurochem 98: 1141-1148, 2006
238. Piantadosi CA and Suliman HB. Redox regulation of mitochondrial biogenesis. Free Radic Biol Med 53: 2043-2053, 2012
239. Pignatelli P, Carnevale R, Cangemi R, Loffredo L, Sanguigni V, Stefanutti C, Basili S, and Violi F. Atorvastatin inhibits gp91phox circulating levels in patients with hypercholesterolemia. Arterioscler Thromb Vasc Biol 30: 360-367, 2010
240. Pletjushkina OY, Lyamzaev KG, Popova EN, Nepryakhina OK, Ivanova OY, Domnina LV, Chernyak BV, and Skulachev VP. Effect of oxidative stress on dynamics of mitochondrial reticulum. Biochim Biophys Acta 1757: 518-524, 2006
241. Plotnikov EY, Chupyrkina AA, Jankauskas SS, Pevzner IB, Silachev DN, Skulachev VP, and Zorov DB. Mechanisms of nephroprotective effect of mitochondria-Targeted antioxidants under rhabdomyolysis and ischemia/reperfusion. Biochim Biophys Acta 1812: 77-86, 2011
242. Plotnikov EY, Morosanova MA, Pevzner IB, Zorova LD, Manskikh VN, Pulkova NV, Galkina SI, Skulachev VP, and Zorov DB. Protective effect of mitochondria-Targeted antioxidants in an acute bacterial infection. Proc Natl Acad Sci U S A 110: E3100-E3108, 2013
243. Plotnikov EY, Silachev DN, Chupyrkina AA, Danshina MI, Jankauskas SS, Morosanova MA, Stelmashook EV, Vasileva AK, Goryacheva ES, Pirogov YA, Isaev NK, and Zorov DB. New-generation Skulachev ions exhibiting nephroprotective and neuroprotective properties. Biochemistry (Mosc) 75: 145-150, 2010
244. Podmore ID, Griffiths HR, Herbert KE, Mistry N, Mistry P, and Lunec J. Vitamin C exhibits pro-oxidant properties. Nature 392: 559, 1998
245. Popot JL and de Vitry C. On the microassembly of integral membrane proteins. Annu Rev Biophys Biophys Chem 19: 369-403, 1990
246. Porteous CM, Logan A, Evans C, Ledgerwood EC, Menon DK, Aigbirhio F, Smith RA, and Murphy MP. Rapid uptake of lipophilic triphenylphosphonium cations by mitochondria in vivo following intravenous injection: implications for mitochondria-specific therapies and probes. Biochim Biophys Acta 1800: 1009-1017, 2010
247. Poulsen MM, Vestergaard PF, Clasen BF, Radko Y, Christensen LP, Stødkilde-Jørgensen H, Møller N, Jessen N, Pedersen SB, and Jørgensen JO. High-dose resveratrol supplementation in obese men: an investigator-initiated, randomized, placebocontrolled clinical trial of substratemetabolism, insulin sensitivity, and body composition. Diabetes 62: 1186-1195, 2013
248. Powers SK and Jackson MJ. Exercise-induced oxidative stress: cellular mechanisms and impact on muscle force production. Physiol Rev 88: 1243-1276, 2008
249. Praticò D. Oxidative stress hypothesis in Alzheimers disease: a reappraisal. Trends Pharmacol Sci 29: 609-615, 2008
250. Price NL, Gomes AP, Ling AJ, Duarte FV, Martin-Montalvo A, North BJ, Agarwal B, Ye L, Ramadori G, Teodoro JS, Hubbard BP, Varela AT, Davis JG, Varamini B, Hafner A, Moaddel R, Rolo AP, Coppari R, Palmeira CM, de Cabo R, Baur JA, and Sinclair DA. SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function. Cell Metab 15: 675-690, 2012
251. Przyklenk K. Pharmacologic treatment of the stunned myocardium: the concepts and the challenges. Coron Artery Dis 12: 363-369, 2001
252. Pung YF, Rocic P, Murphy MP, Smith RA, Hafemeister J, Ohanyan V, Guarini G, Yin L, and Chilian WM. Resolution of mitochondrial oxidative stress rescues coronary collateral growth in Zucker obese fatty rats. Arterioscler Thromb Vasc Biol 32: 325-334, 2012
253. Quin C, Robertson L, McQuaker SJ, Price NC, Brand MD, and Hartley RC. Caged mitochondrial uncouplers that are released in response to hydrogen peroxide. Tetrahedron 66: 2384-2389, 2010
254. Radi R, Rodriguez M, Castro L, and Telleri R. Inhibition of mitochondrial electron transport by peroxynitrite. Arch Biochem Biophys 308: 89-95, 1994
255. Rahman I and MacNee W. Regulation of redox glutathione levels and gene transcription in lung inflammation: therapeutic approaches. Free Radic Biol Med 28: 1405-1420, 2000
256. Rahman M, Mofarrahi M, Kristof AS, Nkengfac B, Harel S, and Hussain SN. Reactive oxygen species regulation of autophagy in skeletal muscles. Antioxid Redox Signal 20: 443-459, 2014
257. Rahman ST, Merchant N, Haque T, Wahi J, Bhaheetharan S, Ferdinand KC, and Khan BV. The impact of lipoic acid on endothelial function and proteinuria in Quinapriltreated diabetic patients with stage I hypertension: results from the quality study. J Cardiovasc Pharmacol Ther 17: 139-145, 2012
258. Rains JL and Jain SK. Oxidative stress, insulin signaling, and diabetes. Free Radic Biol Med 50: 567-575, 2011
259. Rao VA, Klein SR, Bonar SJ, Zielonka J, Mizuno N, Dickey JS, Keller PW, Joseph J, Kalyanaraman B, and Shacter E. The antioxidant transcription factor Nrf2 negatively regulates autophagy and growth arrest induced by the anticancer redox agent mitoquinone. J Biol Chem 285: 34447-34459, 2010
260. Rapola JM, Virtamo J, Ripatti S, Huttunen JK, Albanes D, Taylor PR, and Heinonen OP. Randomised trial of alphatocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet 349: 1715-1720, 1997
261. Reddy PH, Tripathi R, Troung Q, Tirumala K, Reddy TP, Anekonda V, Shirendeb UP, Calkins MJ, Reddy AP, Mao P, and Manczak M. Abnormal mitochondrial dynamics Alzheimers disease: implications to mitochondria-Targeted antioxidant therapeutics. Biochim Biophys Acta 1822: 639-649, 2012
262. Reily C, Mitchell TF, Chacko BK, Benavides G, Murphy MP, and Darley-Usmar V. Mitochondrially targeted compounds and their impact on cellular bioenergetics. Redox Biol 1: 86-93, 2013
263. Remondino A, Kwon SH, Communal C, Pimentel DR, Sawyer DB, Singh K, and Colucci WS. Beta-Adrenergic receptor-stimulated apoptosis in cardiac myocytes is mediated by reactive oxygen species/c-Jun NH2-Terminal kinase-dependent activation of the mitochondrial pathway. Circ Res 92: 136-138, 2003
264. Riedl MA, Saxon A, and Diaz-Sanchez D. Oral sulforaphane increases phase II antioxidant enzymes in the human upper airway. Clin Immunol 130: 244-251, 2009
265. Rindler PM, Plafker SM, Szweda LI, and Kinter M. High dietary fat selectively increases catalase expression within cardiac mitochondria. J Biol Chem 288: 1979-1990, 2013
266. Ristow M, Zarse K, Oberbach A, Klöting N, Birringer M, Kiehntopf M, Stumvoll M, Kahn CR, and Blüher M. Antioxidants prevent health-promoting effects of physical exercise in humans. Proc Natl Acad Sci U S A 106: 8665-8670, 2009
267. Robertson L and Hartley RC. Synthesis of N-Arylpyridinium salts bearing a nitrone spin trap as potential mitochondria-Targeted antioxidants. Tetrahedron 65: 5284-5292, 2009
268. Rocha M, Apostolova N, Herance JR, Rovira-Llopis S, Hernandez-Mijares A, and Victor VM. Perspectives and potential applications of mitochondria-Targeted antioxidants in cardiometabolic diseases and type 2 diabetes. Med Res Rev 34: 160-189, 2014
269. Rocha M, Rovira-Llopis S, Bañuls C, Bellod L, Falcon R, Castello R, Morillas C, Herance JR, Hernandez-Mijares A, and Victor VM. Mitochondrial dysfunction and oxidative stress in insulin resistance. Curr Pharm Des 19: 5730-5741, 2013
270. Rocha M, Rovira-Llopis S, Herance JR, Bañuls C, Polo M, Blas-Garcia A, Hernandez-Mijares A, and Victor VM. The pivotal role of nitric oxide: effects on the nervous and immune systems. Curr Pharm Des 20: 4679-4689, 2014
271. Rodriguez-Cuenca S, Cochemé HM, Logan A, Abakumova I, Prime TA, Rose C, Vidal-Puig A, Smith AC, Rubinsztein DC, Fearnley IM, Jones BA, Pope S, Heales SJ, Lam BY, Neogi SG, McFarlane I, James AM, Smith RA, and Murphy MP. Consequences of long-Term oral administration of the mitochondria-Targeted antioxidant MitoQ to wild-Type mice. Free Radic Biol Med 48: 161-172, 2010
272. Roser KS, Brookes PS, Wojtovich AP, Olson LP, Shojaie J, Parton RL, and Anders MW. Mitochondrial biotransformation of omega-(phenoxy)alkanoic acids, 3-(phenoxy)acrylic acids, and omega-(1-methyl-1H-imidazol-2-ylthio)alkanoic acids: a prodrug strategy for targeting cytoprotective antioxidants to mitochondria. Bioorg Med Chem 18: 1441-1448, 2010
273. Ross MF, Prime TA, Abakumova I, James AM, Porteous CM, Smith RA, and Murphy MP. Rapid and extensive uptake and activation of hydrophobic triphenylphosphonium cations within cells. Biochem J 411: 633-645, 2008
274. Rougee M, Bensasson RV, Land EJ, and Pariente R. Deactivation of singlet molecular oxygen by thiols and related compounds, possible protectors against skin photosensitivity. Photochem Photobiol 47: 485-489, 1988
275. Rovira-Llopis S, Bañuls C, Apostolova N, Morillas C, Hernandez-Mijares A, Rocha M, and Victor VM. Is glycemic control modulating endoplasmic reticulum stress in leukocytes of type 2 diabetic patients? Antioxid Redox Signal 21: 1759-1765, 2014
276. Rovira-Llopis S, Rocha M, Falcon R, de Pablo C, Alvarez A, Jover A, Hernandez-Mijares A, and Victor VM. Is myeloperoxidase a key component in the ROS-induced vascular damage related to nephropathy in type 2 diabetes? Antioxid Redox Signal 19: 1452-1458, 2013
277. Rozenberg O, Shih DM, and Aviram M. Paraoxonase 1 (PON1) attenuates macrophage oxidative status: studies in PON1 transfected cells and in PON1 transgenic mice. Atherosclerosis 181: 9-18, 2005
278. Ruttkay-Nedecky B, Nejdl L, Gumulec J, Zitka O, Masarik M, Eckschlager T, Stiborova M, Adam V, and Kizek R. The role of metallothionein in oxidative stress. Int J Mol Sci 14: 6044-6066, 2013
279. Saito C, Zwingmann C, and Jaeschke H. Novel mechanisms of protection against acetaminophen hepatotoxicity in mice by glutathione and N-Acetylcysteine. Hepatology 51: 246-254, 2010
280. Salvi M, Battaglia V, Brunati AM, La Rocca N, Tibaldi E, Pietrangeli P, Marcocci L, Mondovì B, Rossi CA, and Toninello A. Catalase takes part in rat liver mitochondria oxidative stress defense. J Biol Chem 282: 24407-24415, 2007
281. Satarkov AA, Fiskum G, Chinopoulos C, Lorenzo BJ, Browne SE, Patel MS, and Beal MF. Mitochondrial aketoglutarate dehydrogenase complex generates reactive oxygen species. J Neurosci 24: 7779-7788, 2004
282. Sayin VI, Ibrahim MX, Larsson E, Nilsson JA, Lindahl P, and Bergo MO. Antioxidants accelerate lung cancer progression in mice. Sci Transl Med 6: 221ra15, 2014
283. Schrader M. Shared components of mitochondrial and peroxisomal division. Biochim Biophys Acta 1763: 531-541, 2006
284. Scherz-Shouval R, Shvets E, Fass E, Shorer H, Gil L, and Elazar Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J 26: 1749-1760, 2007
285. Schulz E, Anter E, and Keaney JF. Oxidative stress, antioxidants, and endothelial function. Curr Med Chem 11: 1093-1104, 2004
286. Sen S, Kawahara B, and Chaudhuri G. Mitochondrialassociated nitric oxide synthase activity inhibits cytochrome c oxidase: implications for breast cancer. Free Radic Biol Med 57: 210-220, 2013
287. Serviddio G, Bellanti F, Sastre J, Vendemiale G, and Altomare E. Targeting mitochondria: a new promising approach for the treatment of liver diseases. Curr Med Chem 17: 2325-2337, 2010
288. Sesso HD, Buring JE, Christen WG, Kurth T, Belanger C, MacFadyen J, Bubes V, Manson JE, Glynn RJ, and Gaziano JM. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians Health Study II randomized controlled trial. JAMA 300: 2123-2133, 2008
289. Severin FF, Severina II, Antonenko YN, Rokitskaya TI, Cherepanov DA, Mokhova EN, Vyssokikh MY, Pustovidko AV, Markova OV, Yaguzhinsky LS, Korshunova GA, Sumbatyan NV, Skulachev MV, and Skulachev VP. Penetrating cation/fatty acid anion pair as a mitochondria-Targeted protonophore. Proc Natl Acad Sci U S A 107: 663-668, 2010
290. Severina II, Severin FF, Korshunova GA, Sumbatyan NV, Ilyasova TM, Simonyan RA, Rogov AG, Trendeleva TA, Zvyagilskaya RA, Dugina VB, Domnina LV, Fetisova EK, Lyamzaev KG, Vyssokikh MY, Chernyak BV, Skulachev MV, Skulachev VP, and Sadovnichii VA. In search of novel highly active mitochondria-Targeted antioxidants: thymoquinone and its cationic derivatives. FEBS Lett 587: 2018-2024, 2013
291. Shenouda SM, Widlansky ME, Chen K, Xu G, Holbrook M, Tabit CE, Hamburg NM, Frame AA, Caiano TL, Kluge MA, Duess MA, Levit A, Kim B, Hartman ML, Joseph L, Shirihai OS, and Vita JA. Altered mitochondrial dynamics contributes to endothelial dysfunction in diabetes mellitus. Circulation 124: 444-453, 2011
292. Skulachev VP. Cationic antioxidants as a powerful tool against mitochondrial oxidative stress. Biochem Biophys Res Commun 441: 275-279, 2013
293. Skulachev VP, Anisimov VN, Antonenko YN, Bakeeva LE, Chernyak BV, Erichev VP, Filenko OF, Kalinina NI, Kapelko VI, Kolosova NG, Kopnin BP, Korshunova GA, Lichinitser MR, Obukhova LA, Pasyukova EG, Pisarenko OI, Roginsky VA, Ruuge EK, Senin II, Severina II, Skulachev MV, Spivak IM, Tashlitsky VN, Tkachuk VA, Vyssokikh MY, Yaguzhinsky LS, and Zorov DB. An attempt to prevent senescence: a mitochondrial approach. Biochim Biophys Acta 1787: 437-461, 2009
294. Smith RA, Adlam VJ, Blaikie FH, Manas AR, Porteous CM, James AM, Ross MF, Logan A, Cochemé HM, Trnka J, Prime TA, Abakumova I, Jones BA, Filipovska A, and Murphy MP. Mitochondria-Targeted antioxidants in the treatment of disease. Ann N Y Acad Sci 1147: 105-111, 2008
295. Smith RA, Hartley RC, Cochemé HM, and Murphy MP. Mitochondrial pharmacology. Trends Pharmacol Sci 33: 341-352, 2012
296. Smith RA and Murphy MP. Animal and human studies with the mitochondria-Targeted antioxidant MitoQ. Ann N Y Acad Sci 1201: 96-103, 2010
297. Smith RA and Murphy MP. Mitochondria-Targeted antioxidants as therapies. Discov Med 11: 106-114, 2011
298. Smith RA, Porteous CM, Coulter CM, and Murphy MP. Selective targeting of an antioxidant to mitochondria. Eur J Biochem 263: 709-716, 1999
299. Smith RA, Porteous CM, Gane AM, and Murphy MP. Delivery of bioactive molecules to mitochondria in vivo. Proc Natl Acad Sci U S A 100: 5407-5412, 2003
300. Soh N. Recent advances in fluorescent probes for the detection of reactive oxygen species. Anal Bioanal Chem 386: 532-543, 2006
301. Sovari AA, Rutledge CA, Jeong EM, Dolmatova E, Arasu D, Liu H, Vahdani N, Gu L, Zandieh S, Xiao L, Bonini MG, Duffy HS, and Dudley SC. Mitochondria oxidative stress, connexin43 remodeling, and sudden arrhythmic death. Circ Arrhythm Electrophysiol 6: 623-631, 2013
302. Spasojević I, Chen Y, Noel TJ, Yu Y, Cole MP, Zhang L, Zhao Y, St. Clair DK, and Batinić-Haberle I. Mn porphyrin-based superoxide dismutase (SOD) mimic, MnIIITE-2-PyP5 + , targets mouse heart mitochondria. Free Radic Biol Med 42: 1193-1200, 2007
303. Speakman JR, Talbot DA, Selman C, Snart S, McLaren JS, Redman P, Krol E, Jackson DM, Johnson MS, and Brand MD. Uncoupled and surviving: individual mice with high metabolism have greater mitochondrial uncoupling and live longer. Aging Cell 3: 87-95, 2004
304. Srinivasan V, Doctrow S, Singh VK, and Whitnall MH. Evaluation of EUK-189, a synthetic superoxide dismutase/catalase mimetic as a radiation countermeasure. Immunopharmacol Immunotoxicol 30: 271-290, 2008
305. Stefanova NA, Muraleva NA, Skulachev VP, and Kolosova NG. Alzheimers disease-like pathology in senescence-Accelerated OXYS rats can be partially retarded with mitochondria-Targeted antioxidant SkQ1. J Alzheimers Dis 38: 681-694, 2014
306. Steinberg SF. Oxidative stress and sarcomeric proteins. Circ Res 112: 393-405, 2013
307. Stey C, Steurer J, Bachmann S, Medici TC, and Tramer MR. The effect of oral N-Acetylcysteine in chronic bronchitis: a quantitative systematic review. Eur Respir J 16: 253-262, 2000
308. Stone WL and Smith M. Therapeutic uses of antioxidant liposomes. Mol Biotechnol 27: 217-230, 2004
309. Suarna C, Wu BJ, Choy K, Mori T, Croft K, Cynshi O, and Stocker R. Protective effect of vitamin E supplements on experimental atherosclerosis is modest and depends on preexisting vitamin E deficiency. Free Radic Biol Med 41: 722-730, 2006
310. Suh JH, Shigeno ET, Morrow JD, Cox B, Rocha AE, Frei B, and Hagen TM. Oxidative stress in the aging rat heart is reversed by dietary supplementation with (R)-(alpha)-lipoic acid. FASEB J 15: 700-706, 2001
311. Sukhanova EI, Trendeleva TA, and Zvyagilskaya RA. Interaction of yeast mitochondria with fatty acids and mitochondria-Targeted lipophilic cations. Biochemistry (Mosc) 75: 139-144, 2010
312. Sung S, Yao Y, Uryu K, Yang H, Lee VM, Trojanowski JQ, and Praticò D. Early vitamin E supplementation in young but not aged mice reduces Abeta levels and amyloid deposition in a transgenic model of Alzheimers disease. FASEB J 18: 323-325, 2004
313. Supinski GS, Murphy MP, and Callahan LA. MitoQ administration prevents endotoxin-induced cardiac dysfunction. Am J Physiol Regul Integr Comp Physiol 297: 1095-1102, 2009
314. Suzuki T, Motohashi H, and Yamamoto M. Toward clinical application of the Keap1-Nrf2 pathway. Trends Pharmacol Sci 34: 340-346, 2013
315. Szeto HH. Cell-permeable, mitochondrial-Targeted, peptide antioxidants. AAPS J 8: 277-283, 2006
316. Szeto HH. Mitochondria-Targeted cytoprotective peptides for ischemia-reperfusion injury. Antioxid Redox Signal 10: 601-619, 2008
317. Szeto HH and Schiller PW. Novel therapies targeting inner mitochondrial membrane-from discovery to clinical development. Pharm Res 28: 2669-2679, 2011
318. Tadic V, Prell T, Lautenschlaeger J, and Grosskreutz J. The ER mitochondria calcium cycle and ER stress response as therapeutic targets in amyotrophic lateral sclerosis. Front Cell Neurosci 8: 147, 2014
319. Tanno M, Kuno A, Yano T, Miura T, Hisahara S, Ishikawa S, Shimamoto K, and Horio Y. Induction of manganese superoxide dismutase by nuclear translocation and activation of SIRT1 promotes cell survival in chronic heart failure. J Biol Chem 285: 8375-8382, 2010
320. Tattersall AB, Bridgman KM, and Huitson A. Acetylcysteine (Fabrol) in chronic bronchitis-A study on general practice. J Int Med Res 11: 279-284, 1983
321. Teicher BA, Holden SA, and Cathcart KN. Efficacy of Pt(Rh-123)2 as a radiosensitizer with fractionated X rays. Int J Radiat Oncol Biol Phys 13: 1217-1224, 1987
322. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers inmale smokers. N Engl J Med 330: 1029-1035, 1994
323. Tian N, Moore RS, Braddy S, Rose RA, Gu JW, Hughson MD, and Manning RD, Jr. Interactions between oxidative stress and inflammation in salt-sensitive hypertension. Am J Physiol Heart Circ Physiol 293: 3388-3395, 2007
324. Timmers S, Hesselink MK, and Schrauwen P. Therapeutic potential of resveratrol in obesity and type 2 diabetes: new avenues for health benefits? Ann N Y Acad Sci 1290: 83-89, 2013
325. Timmers S, Konings E, Bilet L, Houtkooper RH, van de Weijer T, Goossens GH, Hoeks J, van der Krieken S, Ryu D, Kersten S, Moonen-Kornips E, Hesselink MK, Kunz I, Schrauwen-Hinderling VB, Blaak EE, Auwerx J, and Schrauwen P. Calorie restriction-like effects of 30 days of resveratrol supplementation on energy metabolism and metabolic profile in obese humans. Cell Metab 14: 612-622, 2011
326. Tovmasyan A, Sheng H, Weitner T, Arulpragasam A, Lu M, Warner DS, Vujaskovic Z, Spasojevic I, and Batinic-Haberle I. Design, mechanism of action, bioavailability and therapeutic effects of mn porphyrin-based redox modulators. Med Princ Pract 22: 103-130, 2013
327. Townsend DM, Tew KD, and Tapiero H. The importance of glutathione in human disease. Biomed Pharmacother 57: 145-155, 2003
328. Toyama S, Shimoyama N, Ishida Y, Koyasu T, Szeto HH, and Shimoyama M. Characterization of acute and chronic neuropathies induced by oxaliplatin in mice and differential effects of a novel mitochondria-Targeted antioxidant on the neuropathies. Anesthesiology 120: 459-473, 2014
329. Treweeke AT, Winterburn TJ, MacKenzie I, Barrett F, Barr C, Rushworth GF, Dransfield I, MacRury SM, and Megson IL. N-Acetylcysteine inhibits platelet-monocyte conjugation in patients with type 2 diabetes with depleted intraplatelet glutathione: a randomised controlled trial. Diabetologia 55: 2920-2928, 2012
330. Trnka J, Blaikie FH, Smith RA, and Murphy MP A mitochondria-Targeted nitroxide is reduced to its hydroxylamine by ubiquinol in mitochondria. Free Radic Biol Med 44: 1406-1419, 2008
331. Tward A, Xia YR, Wang XP, Shi YS, Park C, Castellani LW, Lusis AJ, and Shih DM. Decreased atherosclerotic lesion formation in human serum paraoxonase transgenic mice. Circulation 106: 484-490, 2002
332. Ureshino RP, Rocha KK, Lopes GS, Bincoletto C, and Smaili SS. Calcium signaling alterations, oxidative stress, and autophagy in aging. Antioxid Redox Signal 21: 123-137, 2014
333. Vaidya B, Paliwal R, Rai S, Khatri K, Goyal AK, Mishra N, and Vyas SP. Cell-selective mitochondrial targeting: a new approach for cancer therapy. Cancer Ther 7: 141-148, 2009
334. Vang O. What is new for resveratrol? Is a new set of recommendations necessary? Ann N Y Acad Sci 1290: 1-11, 2013
335. Vergeade A, Mulder P, Vendeville-Dehaudt C, Estour F, Fortin D, Ventura-Clapier R, Thuillez C, and Monteil C. Mitochondrial impairment contributes to cocaine-induced cardiac dysfunction: prevention by the targeted antioxidant MitoQ. Free Radic Biol Med 49: 748-756, 2010
336. Victor VM, Rocha M, Herance R, and Hernandez-Mijares A. Oxidative stress and mitochondrial dysfunction in type 2 diabetes. Curr Pharm Des 17: 3947-3958, 2011
337. Wang B, Sun J, Ma Y, Wu G, Tian Y, Shi Y, and Le G. Resveratrol preserves mitochondrial function, stimulates mitochondrial biogenesis, and attenuates oxidative stress in regulatory T cells of mice fed a high-fat diet. J Food Sci 79: 1823-1831, 2014
338. Wang JX, Jiao JQ, Li Q, Long B, Wang K, Liu JP, Li YR, and Li PF. miR-499 regulates mitochondrial dynamics by targeting calcineurin and dynamin-related protein-1. Nat Med 17: 71-78, 2011
339. Wang M, Lang X, Cui S, Zou L, Cao J, Wang S, and Wu X. Quantitative assessment of the influence of paraoxonase 1 activity and coronary heart disease risk. DNA Cell Biol 31: 975-982, 2012
340. Wang Q, Xu J, Rottinghaus GE, Simonyi A, Lubahn D, Sun GY, and Sun AY. Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res 958: 439-447, 2002
341. Wang X, Yu Y, Ji L, Liang X, Zhang T, and Hai C. Alpha lipoic acid protects against myocardial ischemia/reperfusion injury via multiple target effects. Food Chem Toxicol 49: 2750-2757, 2011
342. Wani WY, Gudup S, Sunkaria A, Bal A, Singh PP, Kandimalla RJ, Sharma DR, and Gill KD. Protective efficacy of mitochondrial targeted antioxidant MitoQ against dichlorvos induced oxidative stress and cell death in rat brain. Neuropharmacology 61: 1193-1201, 2011
343. Warburton DE, Nicol CW, and Bredin SS. Health benefits of physical activity: the evidence. Can Med Ass J 174: 801-809, 2006
344. Wasiak S, Zunino R, and McBride HM. Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria Turing apoptotic cell death. J Cell Biol 177: 439-450, 2007
345. Watson PS, Scalia GM, Galbraith A, Burstow DJ, Bett N, and Aroney CN. Lack of effect of coenzyme Q on left ventricular function in patients with congestive heart failure. J Am Coll Cardiol 33: 1549-1552, 1999
346. Waypa GB, Guzy R, Mungai PT, Mack MM, Marks JD, Roe MW, and Schumacker PT. Increases in mitochondrial reactive oxygen species trigger hypoxia-induced calcium responses in pulmonary artery smooth muscle cells. Circ Res 99: 970-978, 2006
347. Waypa GB, Marks JD, Guzy RD, Mungai PT, Schriewer JM, Dokic D, Ball MK, and Schumacker PT. Superoxide generated at mitochondrial complex III triggers acute responses to hypoxia in the pulmonary circulation. Am J Respir Crit Care Med 187: 424-432, 2013
348. Wedgwood S and Steinhorn RH. Role of reactive oxygen species in neonatal pulmonary vascular disease. Antioxid Redox Signal 21: 1926-1942, 2014
349. Weissig V, DSouza GG, and Torchilin VP. DQAsome/DNA complexes release DNA upon contact with isolated mouse liver mitochondria. J Control Release 75: 401-408, 2001
350. Wenzel P, Daiber A, Oelze M, Brandt M, Closs E, Xu J, Thum T, Bauersachs J, Ertl G, Zou MH, Förstermann U, and Münzel T. Mechanisms underlying recoupling of eNOS by HMG-CoA reductase inhibition in a rat model of streptozotocininduced diabetes mellitus. Atherosclerosis 198: 65-76, 2008
351. Weyer G, Babej-Dolle RM, Hadler D, Hofmann S, and Herrmann WM A controlled study of 2 doses of idebenone in the treatment of Alzheimers disease. Neuropsychobiology 36: 73-82, 1997
352. Whiteman M, Spencer JP, Szeto HH, and Armstrong JS. Do mitochondriotropic antioxidants prevent chlorinative stress-induced mitochondrial and cellular injury? Antioxid Redox Signal 10: 641-650, 2008
353. Wilcox CS and Pearlman A. Chemistry and antihypertensive effects of tempol and other nitroxides. Pharmacol Rev 60: 418-469, 2008
354. Wipf P, Xiao J, Jiang J, Belikova NA, Tyurin VA, Fink MP, and Kagan VE. Mitochondrial targeting of selective electron scavengers: synthesis and biological analysis of hemigramicidin-TEMPO conjugates. J Am Chem Soc 127: 12460-12461, 2005
355. Wong CH, Iskandar KB, Yadav SK, Hirpara JL, Loh T, and Pervaiz S. Simultaneous induction of non-canonical autophagy and apoptosis in cancer cells by ROSdependent ERK and JNK activation. PLoS One 5: e9996, 2010
356. Wray DW, Nishiyama SK, Harris RA, Zhao J, McDaniel J, Fjeldstad AS, Witman MA, Ives SJ, Barrett-OKeefe Z, and Richardson RS. Acute reversal of endothelial dysfunction in the elderly after antioxidant consumption. Hypertension 59: 818-824, 2012
357. Wu TW, Hashimoto N, Au JX, Wu J, Mickle DA, and Carey D. Trolox protects rat hepatocytes against oxyradical damage and the ischemic rat liver from reperfusion injury. Hepatology 13: 575-580, 1991
358. Wu TW, Hashimoto N, Wu J, Cavey D, Li, RK, Micle DA, and Weisel RD. The cytoprotective effect of Trolox demonstrated with three types of human cells. Biochem Cell Biol 68: 1189-1194, 1990
359. Xia N, Daiber A, Habermeier A, Closs EI, Thum T, Spanier G, Lu Q, Oelze M, Torzewski M, Lackner KJ, Münzel T, Förstermann U, and Li H. Resveratrol reverses endothelial nitric-oxide synthase uncoupling in apolipoprotein E knockout mice. J Pharmacol Exp Ther 335: 149-154, 2010
360. Xie YW, Kaminski PM, and Wolin MS. Inhibition of rat cardiac muscle contraction and mitochondrial respiration by endogenous peroxynitrite formation during posthypoxic reoxygenation. Circ Res 82: 891-897, 1998
361. Yamada Y, Furukawa R, Yasuzaki Y, and Harashima H. Dual function MITO-Porter, a nano carrier integrating both efficient cytoplasmic delivery and mitochondrial macromolecule delivery. Mol Ther 19: 1449-1456, 2011
362. Yamada Y and Harashima H. Mitochondrial drug delivery systems for macromolecule and their therapeutic application to mitochondrial diseases. Adv Drug Deliv Rev 60: 1439-1462, 2008
363. Yamada Y and Harashima H. Enhancement in selective mitochondrial association by direct modification of a mitochondrial targeting signal peptide on a liposomal based nanocarrier. Mitochondrion 13: 526-532, 2013
364. Yan LJ, Levine RL, and Sohal RS. Oxidative damage during aging targets mitochondrial aconitase. Proc Natl Acad Sci U S A 94: 11168-11172, 1997
365. Yang J, Wu LJ, Tashino S, Onodera S, and Ikejima T. Reactive oxygen species and nitric oxide regulate mitochondria-dependent apoptosis and autophagy in evodiamine-Treated human cervix carcinoma HeLa cells. Free Radic Res 42: 492-504, 2008
366. Yang L, Zhao K, Calingasan NY, Luo G, Szeto HH, and Beal MF. Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1, 2, 3, 6-Tetrahydropyridine neurotoxicity. Antioxid Redox Signal 11: 2095-2104, 2009
367. Ye B, Maret W, and Vallee BL. Zinc metallothionein imported into liver mitochondria modulates respiration. Proc Natl Acad Sci U S A 98: 2317-2322, 2001
368. Yee C, Yang W, and Hekimi S. The intrinsic apoptosis pathway mediates the pro-longevity response to mitochondrial ROS in C. elegans. Cell 157: 897-909, 2014
369. Yoshino J, Conte C, Fontana L, Mittendorfer B, Imai S, Schechtman KB, Gu C, Kunz I, Rossi Fanelli F, Patterson BW, and Klein S. Resveratrol supplementation does not improve metabolic function in nonobese women with normal glucose tolerance. Cell Metab 16: 658-664, 2012
370. Yousif LF, Stewart KM, Horton KL, and Kelley SO. Mitochondria-penetrating peptides: sequence effects and model cargo transport. Chembiochem 10: 2081-2088, 2009
371. Yousif LF, Stewart KM, and Kelley SO. Targeting mitochondria with organelle-specific compounds: strategies and applications. Chembiochem 10: 1939-1950, 2009
372. Yu T, Robotham JL, and Yoon Y. Increased production of reactive oxygen species in hyperglycemic conditions requires dynamic change of mitochondrial morphology. Proc Natl Acad Sci U S A 103: 2653-2658, 2006
373. Zang QS, Sadek H, Maass DL, Martinez B, Ma L, Kilgore JA, Williams NS, Frantz DE, Wigginton JG, Nwariaku FE, Wolf SE, and Minei JP. Specific inhibition of mitochondrial oxidative stress suppresses inflammation and improves cardiac function in a rat pneumonia-related sepsis model. Am J Physiol Heart Circ Physiol 302: 1847-1859, 2012
374. Zhang E, Zhang C, Su Y, Cheng T, and Shi C. Newly developed strategies for multifunctional mitochondriatargeted agents in cancer therapy. Drug Discov Today 16: 140-146, 2011
375. Zhang H, Kong X, Kang J, Su J, Li Y, Zhong J, and Sun L. Oxidative stress induces parallel autophagy and mitochondria dysfunction in human glioma U251 cells. Toxicol Sci 110: 376-388, 2009
376. Zhang Y, Han P, Wu N, He B, Lu Y, Li S, Liu Y, Zhao S, Liu L, and Li Y. Amelioration of lipid abnormalities by alipoic acid through antioxidative and anti-inflammatory effects. Obesity (Silver Spring) 19: 1647-1653, 2011
377. Zhao K, Luo G, Zhao GM, Schiller PW, and Szeto HH. Transcellular transport of a highly polar 3 + net charge opioid tetrapeptide. J Pharmacol Exp Ther 304: 425-432, 2003
378. Zhao K, Zhao GM, Wu D, Soong Y, Birk AV, Schiller PW, and Szeto HH. Cell-permeable peptide antioxidants targeted to inner mitochondrial membrane inhibit mitochondrial swelling, oxidative cell death, and reperfusion injury. J Biol Chem 279: 34682-34690, 2004
379. Zhu BZ, Mao L, Fan RM, Zhu JG, Zhang YN, Wang J, Kalyanaraman B, and Frei B. Ergothioneine prevents copper-induced oxidative damage to DNA and protein by forming a redox-inactive ergothioneine-copper complex. Chem Res Toxicol 24: 30-34, 2011
380. Zupančič Š , Kocbek P, Zariwala MG, Renshaw D, Gul MO, Elsaid Z, Taylor KM, and Somavarapu S. Design and development of novel mitochondrial targeted nanocarriers, DQAsomes for curcumin inhalation. Mol Pharm 11: 2334-2345, 2014